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Chlamydia trachomatis is a leading cause of sexually transmitted infection worldwide and responsible for myriad of
immunopathological changes associated with reproductive health. Delayed secretion of proinﬂammatory chemokine interleukin
(IL)-8 is a hallmark of chlamydial infection and is dependent on chlamydial growth. We examined the eﬀect of iron chelators on
IL-8 production in HeLa 229 (cervix epitheloid cell, CCL2) cells infected with C. trachomatis. IL-8 production was induced by
Iron chelator DFO and Mimosine, however, synergy with chlamydial infection was obtained with DFO only. Temporal expression
of proinﬂammatory secreted cytokines IL-1beta, TNF-alpha, and IL-8 did not show synchrony in Chlamydia trachomatis infected
cells. Secretion of IL-8 from Hela cells infected with C. trachomatis was not dependent on IL-1 beta and TNF- alpha induction.
These results indicate towards involvement of iron in chlamydia induced IL-8 production.
Copyright © 2009 Harsh Vardhan et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Chlamydia trachomatis is the most common sexually trans-
mitted pathogen which causes severe sequelae in women
including pelvic inﬂammatory disease, ectopic pregnancy,
and infertility [1–4]. C. trachomatis is able to infect and
multiply within a broad range of eukaryotic cells, including
macrophages, smooth muscle, epithelial, and endothelial
cells [5]. Chlamydial infection of epithelial cells at mucosal
surface produces proinﬂammatory factors such as Inter-
leukin (IL)-1α, IL-6, IL-8, IL-11, GRO-α,a n dg r a n u l o c y t e -
macrophage colony-stimulating factor [6–8], which can lead
to an acute inﬂammatory response characterized by neu-
trophil inﬁltration to the primary sites of infection, followed
by a subepithelial accumulation of mononuclear leukocytes
during the chronic phase of infection [9–11]. These cellular
responses promote cellular proliferation and tissue damage
of aﬀected organs [12]. Most of the invasive bacterial
pathogensofteninducerapidbuttransientresponses[13].In
contrast C. trachomatis infection induces delayed proinﬂam-
matory responses especially IL-8 production in epithelial
cells and is dependent on bacterial replication [7, 14, 15]. In
addition Tumor necrosis factor-alpha (TNF-α) and IL-1beta
(IL-1β) have been reported to be the most powerful inducers
of IL-8 in a multitude of cell lines and a major contributor in
clearance process for intracellular pathogens [16, 17].
Bacterial iron chelator (desferal, deferoxamine mesylate)
triggers inﬂammatory signals, including the production of
CXC chemokine IL-8 in human intestinal epithelial cells
(IECs) by activating ERK1/2 and p38 kinase pathways [18].
Chlamydia enters into persistence stage in the presence of
iron-chelating drug (Desferal), thereby showing its depen-
dence on iron for completion of developmental cycle [19].
Persistence can also be induced by antibiosis and tryptophan
starvation induced by penicillin G and IFN-γ respectively
[20–22]. Earlier model of C. pneumoniae persistence showed
that after IFN-γ and penicillin treatment chlamydia-induced
IL-8 expression was inhibited, while it stayed up regulated
in iron-depletion [23]. In order to develop appropriate
therapeutic regimen, it is essential to deﬁne the activation
pathways where iron chelation controls IL-8 induction in
chlamydial infection.2 Mediators of Inﬂammation
Thus, this study aimed to reveal (i) involvement of
intracellular iron in chlamydia induced production of proin-
ﬂammatory cytokine IL-8 from HeLa 229 cells and (ii)
autocrine eﬀect of TNF-α and IL-1β in production of IL-
8f r o mC. trachomatis infected cells under iron deprived
condition.
2.MaterialsandMethods
2.1. Materials. All the biochemicals were purchased from
Sigma-Aldrich (Saint Louis, USA) unless otherwise men-
tioned: (i) Deferoxamine mesylate (DFO)—bacterial iron
chelator; (ii) Mimosine—a plant based iron chelator; (iii)
Ferric ammonium citrate (FAC)—iron source; (iv) Glucose
oxidase (GO)—oxidant; (v) DETA-NANOate—nitric oxide
producer; (vi) Pyrrolidin dithiocarbamate (PDTC)—nitric
oxide inhibitor; (vii) Ebselen—antioxidant.
2.2. Propagation of Chlamydia trachomatis. HeLa 229 cervix
epitheloid cells (CCL2) were maintained in EMEM con-
taining 10μg/mL gentamicin and supplemented with 10%
fetal bovine serum. Further HeLa cells maintained in 50cm2
culture ﬂask were infected with C. trachomatis serovar D
for propagation. After 60 hours postinfection infected cells
were scraped and sonicated (30 cycles of 0.6/0.4 seconds) to
release elementary bodies (EBs) followed by centrifugation
at 3000Xg to remove cellular debris. Supernatant containing
EBs was puriﬁed on discontinuous gradients of Renograﬃn
(Squibb, Montreal, Canada) as described previously [24].
Puriﬁed elementary bodies (EBs) were resuspended in iso-
tonic sucrose-phosphate-glutamate (SPG) buﬀer and stored
at −80
◦C. The infectivity of puriﬁed EBs was titrated by
counting chlamydial inclusion forming units (IFUs) on the
monolayer of HeLa 229 cells grown in a 96-well plate.
2.3. Infection. Subconﬂuent monolayer of HeLa cells in 12
well plates was inoculated with EBs at multiplicities of
infection (moi) 2. The plates were then rocked for 2 hours
at 37
◦C for homogenous infection after which the extra-
cellular bacteria were removed by washing with phosphate
buﬀered saline (PBS). Subsequently cells were cultured in
Delbecco’s Minimum Essential Media (Sigma, Saint Louis,
USA)containing10%FetalbovineSerum(PAALaboratories
GmbH, Pasching, Austria), 10μg/mL gentamicin (Sigma,
Saint Louis, USA), 1μg/mL Amphotericin B (Sigma, Saint
Louis, USA) and incubated at 37
◦Ci n5 %C O 2 environment.
After 2 hours of infection, cells were treated with 0.5mM
deferoxamine (DFO), 1mM mimosine, and 0.5mM ferric
ammonium citrate (FAC) at ﬁnal concentration in diﬀerent
wells with their respective control. Further DETA-NANOate
(1mM) and glucose oxidase (10U/mL) was added in combi-
nation with DFO, Mimosine and FAC. Antioxidant ebselen
(2.5mM) and PDTC (1mM) added respective wells along
with their controls and analysis was performed with 48hpi
supernatant.SupernatantofmockandCTinfectedcellswere
collectedat6,12,24,30,48,72,and96hpi,centrifuged(Rota
4R-B/F, Plastocraft, Mumbai, India) at 12000Xg (10min,
4◦C), and stored at −80
◦C until cytokine assay.
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Figure 1: C. trachomatis infected HeLa 229 cells showing signiﬁ-
cantly (P<0.001) increased levels of IL-8 as detected by ELISA in
comparison to mock infected cells.
2.4. Cytokine Assays Using ELISA. Levels of secreted
cytokines (IL-8, TNF-α and IL-1β) in culture supernatants
were determined using ELISA kit (Pierce Biotechnology
Inc, Rockford, USA and (eBiosciences, San Diego, USA))
having detection limit of 2pg/mL, 4pg/mL, and 8pg/mL.
All the assays were performed in duplicate according to
manufacturer’s instructions.
2.5. Statistical Analysis. A statistical analysis was performed
using GraphPad Prism software (version 5.0). Diﬀerences
were tested for statistical signiﬁcance by 2-way repeated
measurements analysis of variance (ANOVA) followed by
Bonferroni posttest. Every experiment was done twice in
triplicate.
3. Results
3.1.ElevatedLevelofExogenousIL-8inC.trachomatisInfected
Hela 229 Cells. Level of IL-8 was signiﬁcantly increased (P<
0.001) in culture supernatant of C. trachomatis infected cells
compared to mock infected cells. Further signiﬁcant increase
in IL-8 level was observed in C. trachomatis infected cells
in addition to iron chelator deferoxamine (DFO). In time
dependent study signiﬁcantly elevated level of IL-8 secretion
was detected at 12hpi, (P<0.001) in C. trachomatis
infectedcellscomparedtocontrol(mockinfectedHelacells).
F u r t h e ri nc o n t r o lc e l l st w op e a k sw e r es e e na t2 4a n d7 2h p i
through at 30hpi representing a biphasic curve, whereas in
C. trachomatis infected cells secreted IL-8 level represented
a monophasic curve which showed consistently signiﬁcantly
increased levels from 12hpi till 72hpi (P<0.001)
(Figure 1).
3.2. Secretion of IL-8 is Independent of Exogenous IL-1β and
TNF-α in Chlamydia Infected Cells. Temporal expression ofMediators of Inﬂammation 3
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Figure 2: TNF-α concentration as determined by ELISA in C.
trachomatis infected culture supernatant was signiﬁcantly (P<
0.001) increased at early time points (6, 12, and 18hpi) and late
time points (72 and 96 hpi), whereas there was decrease at midtime
points (24, 30 and 48hpi) in comparison to mock infected.
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Figure 3: Levels of IL-1β in supernatants of C. trachomatis infected
culture were signiﬁcantly decreased (P<0.005) at early (6, 12,
and 18hpi) and late (72 and 96hpi) time points in comparison
to mock infected culture, whereas at midtime point no signiﬁcant
(P<0.001) change was observed.
IL-1β and TNF-α was assessed to ascertain the involvement
of these cytokines in IL-8 induction. There was signiﬁcant
increase (P<0.001) in level of secreted TNFα in culture
supernatants during early (6, 12, and 18hpi) and late
phases (72 and 96hpi) (Figure 2) whereas IL-1β levels were
elevated at 30hpi (Figure 3). However, at the midphase of
C. trachomatis growth, level of secreted TNF-α declined,
whereas IL-1β level did not show any deviation from basal
level (Figures 2 and 3) and secretions of TNF-α,I L - 1 β,a n d
IL-8 did not show synergy at diﬀerent time points.
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Figure 4: Gradual increase was detected in levels of IL-8 in culture
supernatants, highest at 30hpi; thereafter, subsequent decrease was
observed from 48hpi onwords in C. trachomatis infected cells
treated with Mimosine. DFO treated cells showed delayed secretion
(12hpi) but consistently elevated levels were detected at all the time
point taken.
3.3. IL-8 Expression with Iron Chelator DFO and Mimosine in
C. trachomatis Infected Hela Cells. Mimosine, a plant based
iron chelator, showed earlier induction of IL-8 at 6hpi in C.
trachomatis infected HeLa cells whereas in presence of DFO
therewasdelayed(12hpi) inductionandwasconsistentatall
time intervals (Figure 4). Gradual increase in IL-8 expression
was detected, being highest at 30hpi which subsequently
declined at 48hpi (Figure 4).
3 . 4 .C h l a m y d i aI n d u c e dI L - 8P r o d u c t i o ni sM e d i a t e db yR e a c -
tive Nitrogen Species in Iron Restricted Condition (Evaluated
at 48hpi). IL-8 production was signiﬁcantly increased (P<
0.001) in C. trachomatis infected HeLa cells after stimulation
withDETA-NANOate(Figure5).Furthersigniﬁcantincrease
(P<0.001, Figure 5) was observed in IL-8 production in
mock and CT infected cells upon co-stimulation with DFO
and NO. However additive eﬀect of DFO and NANOate
was signiﬁcantly higher (P<0.005) in CT infected
cells (Figure 5). Moreover glucose oxidase induced IL-8
production irrespective of CT infected or Mock (P<0.005,
Figure 5). Ebselen and PDTC decreased the production of
IL-8 in all the conditions and signiﬁcantly higher inhibition
(P<0.05, Figure 5) was observed with PDTC (Figure 5).
4. Discussion
Chlamydial infections such as sexually transmitted or
respiratory diseases occur frequently; however, course of
these illnesses tends to be mild. Hence, they often pass
unrecognized and untreated. These predominantly mild
acute infections are considered as possible starting points
of other chronic diseases, such as tubal inﬂammation with
infertility, or reactive arthritis for C. trachomatis [25–27].4 Mediators of Inﬂammation
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Figure 5: IL-8 induction was signiﬁcantly (P<0.001) increased
in C. trachomatis infected HeLa cells after stimulation with DETA-
NANOate and there was synergic eﬀect with DFO. Glucose oxidase
treatment induced IL-8 production at same degree in both the C.
trachomatis infected and Mock conditions (P<0.005). Higher
inhibition (P<0.05) of IL-8 induction was observed after addition
of nitric oxide speciﬁc inhibitor PDTC than ebselen.
Disease outcome of Chlamydial infection is predominantly
governed by mediators of inﬂammation and IL-8 leading
the belligerence. Elevated level of IL-8 is dependent on
chlamydial growth [7] and it is reported that in case of
deferoxamine induced persistence, level of IL-8 remains
higher[23]. Theseobservationsraiseaquestionifchlamydia
isdirectlyinvolvedinIL-8inductionorelseintracellularlevel
of iron is also a contributor ?
In our study it was observed that in C. trachomatis
infected HeLa 229 cells, level of secretory IL-8 increased
signiﬁcantly (P<0.001) at 12hpi till 72hpi in compar-
ison to mock infected cells showing thereby the probable
involvement of early phase of chlamydial diﬀerentiation and
metabolic activities responsible for induction and secretion
of IL-8. This is in accordance with earlier study [28]
wherein it has been shown that C. trachomatis and C.
psittaci up regulate mRNA expression and secretion of the
proinﬂammatory cytokines like IL-8, GROα,G M - C S F ,a n d
IL-6. Further IL-8 production in HeLa 229 cells infected
with C. trachomatis was signiﬁcantly delayed (from 24hpi),
unlike most invasive microorganisms that promote rapid
but transient inﬂammatory response [7]. Elevated level of
IL-8 might help epithelial cells at the mucosal surface to
communicate with professional immune cells in response to
pathogenic insult.
Further it was observed that IL-8 induction is indepen-
dentofTNF-αandIL-1β inC.trachomatisinfectedHeLa229
cells. Earlier studies had also suggested that TNF-α and IL-
1β act as costimulatory signal for IL-8 induction in NF-κB
dependent pathway [29]. Chlamydiae contains a tail serine
protease (Tsp) that selectively cleaves the p65/RelA subunit
of NF-κB to potentially interfere with host inﬂammatory
response [30]. In a recent study lower level of TNF receptor
1 was observed on cell surface of chlamydia infected cells,
inhibiting TNF mediated signaling [31] thereby enticing the
possibility of TNF-α and IL1β independent expression of IL-
8i nC. trachomatis infected HeLa 229 cells.
We also demonstrated that chlamydial infection acts
synergistically with DFO to activate IL-8 secretion. Intra-
cellular level of available iron has been shown to modulate
inﬂammatory mediators and to regulate inﬂammatory pro-
cess in several cell types. Two important signaling pathways
represented by p38 and ERK1/2 are required for DFO-
induced IL-8 secretion [18, 32–34]. IL-8 induced by C.
trachomatis has been shown to be dependent on ERK
and independent of p38 and Jun N-terminal MAPK [35]
showing thereby that chlamydial infection and DFO follow
the same course for IL-8 activation. However, further study
of posttranscriptional mechanisms for DFO induced IL-8
involving p38 or ERK is warranted.
In our study DFO-induced IL-8 was increased by DETA-
NANOate and H2O2 although extent of stimulation is less
than that of NO in HeLa cells infected with C. trachomatis.I t
hasbeenreportedthatNOistheinitialfactorinthesignaling
cascade that mediates IL-8 gene transcriptional activation
by DFO. NF-κB is also an important transcriptional factor
for IL-8 production in cancer cells. PDTC, one of the most
eﬀective inhibitors of NF-κB, inhibits the NO-dependent
induction of the IL-8 gene [36]. It may be elucidating that
NO plays important role in IL-8 induction in C. trachomatis
infected cells treated with DFO.
In C. trachomatis infected cells, Mimosine treatment
showed gradual increase and subsequent decrease in IL-
8 expression. Conversely, delayed induction and consistent
expression of IL-8 expression were observed with DFO. Thus
synergy was observed only with DFO having bacterial origin,
indicating that level of intracellular iron plays an important
role in induction of proinﬂammatory responses. Further
it may indicate towards involvement of iron sequestration
mechanism of chlamydial origin and acquisition of iron
from labile iron pool. Results of this study indicate the
involvement of intracellular iron in activation of IL-8 in
chlamydia infected HeLa 229 cells.
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